RMTI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Rockwell Medical Inc (RMTI) is not a good buy for a beginner investor with a long-term strategy at this time. The company is facing significant financial challenges, with declining revenue, net income, and EPS. Technical indicators are bearish, and there are no positive trading signals or news catalysts to suggest a turnaround. The lack of insider or hedge fund activity further supports a cautious approach.
The technical indicators for RMTI are bearish. The MACD is below zero and negatively contracting, RSI is neutral at 30.234, and moving averages suggest a downward trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 0.91 and resistance at 1.061.
No positive catalysts identified. No recent news, insider activity, or hedge fund interest.
Significant financial deterioration in Q3 2025, with revenue down 43.75% YoY, net income down 222.50% YoY, and EPS down 225.00% YoY. Gross margin also dropped by 21.02%. Technical indicators are bearish, and there is no recent trading activity from Congress or influential figures.
In Q3 2025, Rockwell Medical Inc reported a revenue decline to $15.93M (-43.75% YoY), net income of -$1.75M (-222.50% YoY), and EPS of -0.05 (-225.00% YoY). Gross margin fell to 17.4% (-21.02% YoY). These metrics indicate significant financial struggles.
No data available for analyst ratings or price target changes.
